SpaceX is ripping higher after strong earnings. Analysts see more gains ahead

SpaceX reported Q3 revenue of $14.6 billion, up 161% year over year and 14% above LSEG consensus of $12.7 billion; adjusted EPS of $0.45 also beat the $0.13 forecast, and shares rose 8% after the release. Starlink added 1.6 million consumer subscribers to reach 13.6 million, while executives said AI-linked chip volume production through the Terafab collaboration with Tesla and Intel is targeted within two years. Analysts broadly raised price targets, citing AI/compute and connectivity growth; Bernstein cited an expected annual revenue run rate of at least $100 billion by year-end and $500 billion-$1 trillion ARR by end-2027.

Analysis

The market is pricing a transition from launch economics to a scaled compute platform; the key question is whether announced demand converts into durable, cash-generative workloads. Treat management’s capacity and revenue outlook as a target, not contracted revenue: power access, grid interconnection, GPUs/networking, utilization, customer concentration, and contract duration will determine whether added capacity earns attractive returns or becomes stranded capex. Verify what “ARR” measures and how much is signed, cancellable, and recognized as revenue.

Near term, upward estimate revisions can sustain momentum, but the wide gap between bullish targets and HSBC’s Hold underscores unusually high execution sensitivity. Over 1–3 months, contract disclosures, realized compute pricing/utilization, and power procurement matter more than another capacity ambition. Over 6–18 months, successful deployment could pressure cloud pricing or win workloads at the margin from AMZN, GOOG, and MSFT; near-term compute scarcity also means SpaceX may expand the market rather than displace hyperscaler revenue. Starlink adds a separate recurring-revenue engine, but subscriber growth alone does not establish ARPU, churn, or margins.

INTC and TSLA may gain strategic validation from the chip collaboration, but a two-year production goal is not near-term earnings visibility. The contrarian risk is that investors capitalize several unproven businesses together while underweighting the capital, power, and execution burden. A failed capacity ramp or weak conversion of claimed demand into contracted, utilized capacity would challenge the rerating.

Key Decisions for Investors

• Do not chase the post-results gap on analyst targets alone. Keep SPCX on a catalyst watchlist; consider staged exposure only after verifying contracted compute demand, deployment timing, and financing/capex requirements.
• For an existing SPCX position, trim or hedge into strength if management’s next update does not substantiate workload conversion and utilization. Falsifiers: delayed capacity commissioning, weaker realized pricing, or material slippage in Starship milestones.
• Track AMZN, GOOG, and MSFT for evidence of lost workloads or pricing pressure before taking a short; current supply constraints could support incremental demand across providers rather than immediate share transfer.
• Treat INTC and TSLA exposure through the collaboration as optionality, not an earnings catalyst: revisit only with disclosed production milestones, economics, and customer commitments.